Straight from the Desk

Syz the moment

Live feeds, charts, breaking stories, all day long.

19 Feb 2024

Putting things into perspective:

Despite rising yields and hotter-than-expected inflation, the S&P 500 has continued higher in 2024. Source: Edward Jones

16 Feb 2024

$2.4 Trillion In Options Expire Today

There is over $2.4 trillion of notional in options exposure that will expire on Friday, including $510 billion notional of single stock options. Index options volumes continue to grow, driven by 0DTE/short-dated options. Meanwhile, single stock options volumes have rebounded to an 18-month-high fueled by significant growth in call options volumes. Google searches for "call options" just hit a 2 year high. source : gs, zerohedge

16 Feb 2024

Seasonality

S&P 500 is Now Entering the Worst 2-Week Period of the Year Source : gs, barchart

15 Feb 2024

The US equity market is rivalling 2000 and 1929 in terms of being its most concentrated in history, DB has calculated.

The top 5 stocks Microsoft, Apple, Nvidia, Alphabet & Amazon account for 25% of mkt cap of the S&P 500. source : holgerz

15 Feb 2024

S&P 500 $SPX is now entering the worst 2-week period of the year based on data going back almost 100 years.

Source: Bloomberg

12 Feb 2024

2024 YTD S&P 500 Returns by Sector

source : pauldejong

12 Feb 2024

The S&P500 Index Returns Based on the Year of the Dragon

source : carson

12 Feb 2024

Only 6 weeks into 2024, and the S&P 500 and other indexes have already reached new ATH's.

With the S&P up 5.38% YTD and the Nasdaq showing a 6.75% increase, let's see which stocks are the outperformers so far 1. $SMCI - Super Micro Comp - 160.4% 2. $ARM - ARM - 53.3% 3. $NVDA - Nvidia - 45.7% 4. $PLTR - Palantir - 42.0% 5. $CLFT - Confluent - 35.6% 6. $APPF - AppFolio - 34.9% 7. $META - Meta - 32.2% Source: KoyfinCharts Note: only companies with Mcap >$5B and an Altman Z-Score >3. No biotech companies.

Thinking out loud

Sign up for our weekly email highlighting the most popular posts.

Follow us

Thinking out loud

Investing with intelligence

Our latest research, commentary and market outlooks